Israel Englander Medi Wound Ltd. Transaction History

Millennium Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.35 - $9.8 $17,149 - $124,489	-12,703 Reduced 23.8%	40,664 $57,000
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.35 $15,660 - $27,671	-11,775 Reduced 18.08%	53,367 $98,000
Q1 2022 May 16, 2022	BUY	$1.86 - $3.24 $75,895 - $132,204	40,804 Added 167.66%	65,142 $130,000
Q4 2021 Feb 14, 2022	BUY	$2.2 - $4.01 $53,543 - $97,595	24,338 New	24,338 $57,000
Q2 2021 Aug 16, 2021	SELL	$3.38 - $5.71 $151,522 - $255,973	-44,829 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.77 - $6.05 $3,653 - $5,862	969 Added 2.21%	44,829 $241,000
Q4 2020 Feb 16, 2021	BUY	$3.12 - $4.08 $136,843 - $178,948	43,860 New	43,860 $162,000
Q1 2019 May 14, 2019	SELL	$4.24 - $5.24 $289,867 - $358,232	-68,365 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.95 - $6.55 $67,339 - $111,664	17,048 Added 33.22%	68,365 $278,000
Q3 2018 Nov 14, 2018	SELL	$6.1 - $7.1 $139,757 - $162,668	-22,911 Reduced 30.87%	51,317 $316,000
Q2 2018 Aug 14, 2018	BUY	$5.05 - $7.35 $374,851 - $545,575	74,228 New	74,228 $512,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $683M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.